Institutional Review Board Barriers and Solutions Encountered in the Collaboration Among Pharmacists and Physicians to Improve Outcomes Now Study: a National Multicenter Practice-based Implementation Trial
Overview
Authors
Affiliations
Study Objective: To categorize institutional review board (IRB) challenges and solutions encountered in a multicenter practice-based research network (PBRN) study and to assess the impact of IRB requirements on the willingness of individual principal investigators (PIs) to participate in future PBRN studies.
Design: Descriptive analysis of IRB challenges and solutions encountered in the Collaboration Among Pharmacists and Physicians to Improve Outcomes Now (CAPTION) trial, a multicenter prospective cluster-randomized study conducted by the National Interdisciplinary Primary Care PBRN, and a correlational analysis from a survey of individual site PIs.
Measurements And Main Results: IRB barriers encountered and solutions were categorized for study sites. A survey of study-site PIs was conducted with a correlational analysis assessing the impact of various IRB requirements and the willingness of individual PIs to participate in future PBRN studies; of 31 study sites participating in the CAPTION study, 28 study-site PIs were surveyed. IRBs posed a number of challenges including bias regarding the source of the application, issues regarding study design, study instruments, access to patient records, study procedures, Spanish-only speaking subjects, role of clinic physicians, interdepartmental concerns, and updates at continuing review. Responses from the PI survey (21 of 28 PIs surveyed [75% response rate]) indicated that the willingness of an individual to serve as a PI in the future was inversely related to the perceived difficulty of obtaining initial (rS = -0.599, p=0.004) and continuing (rS = -0.464, p=0.034) IRB approval.
Conclusion: Significant time and resources were required to address various challenges associated with IRB approval, which had a negative impact on an individual PI's willingness to participate in future PBRN projects. A revision of current rules and regulations regarding the protection of human subjects for practice-based studies, improvement in IRB processes, and support from coordinating centers may decrease the burden associated with IRB approval and increase participation in practice-based research.
Adams J, Peng W, Steel A, Lauche R, Moore C, Amorin-Woods L BMJ Open. 2017; 7(9):e015830.
PMID: 28965091 PMC: 5640145. DOI: 10.1136/bmjopen-2017-015830.
Engaging in Collaborative Research: Focus on the Pharmacy Practitioner.
Badowski M, Mazur J, Lam S, Miyares M, Schulz L, Michienzi S Hosp Pharm. 2017; 52(1):33-43.
PMID: 28179739 PMC: 5278912. DOI: 10.1310/hpj5201-33.
Carter B, Ardery G J Am Heart Assoc. 2016; 5(12).
PMID: 27993832 PMC: 5210445. DOI: 10.1161/JAHA.116.004432.
Toga A, Dinov I J Big Data. 2016; 2.
PMID: 26929900 PMC: 4768816. DOI: 10.1186/s40537-015-0016-1.
Cluster randomized trials for pharmacy practice research.
Gums T, Carter B, Foster E Int J Clin Pharm. 2015; 38(3):607-14.
PMID: 26715549 DOI: 10.1007/s11096-015-0205-1.